Dianthus Therapeutics, Inc. /DE/ — All Filings
596 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
425
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
RW
S-1
S-1/A
S-3
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0000950170-25-114293 | Sep 11, 2025 | Sep 9, 2025 |
| 424B5 | 424B5 | 0001193125-25-200399 | Sep 11, 2025 | — |
| 144 | — | 0001950047-25-006899 | Sep 9, 2025 | — |
| 8-K | 8-K | 0001193125-25-197751 | Sep 8, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-198345 | Sep 8, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-022007 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-003605 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-003703 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-108822 | Aug 14, 2025 | — |
| 8-K | 8-K | 0000950170-25-105002 | Aug 7, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-105030 | Aug 7, 2025 | Jun 30, 2025 |
| 4 | 4 | 0000950170-25-076412 | May 22, 2025 | — |
| 4 | 4 | 0000950170-25-076410 | May 22, 2025 | — |
| 4 | 4 | 0000950170-25-076400 | May 22, 2025 | — |
| 3 | 3 | 0000950170-25-076398 | May 22, 2025 | — |
| 4 | 4 | 0000950170-25-076406 | May 22, 2025 | — |
| 4 | 4 | 0000950170-25-076403 | May 22, 2025 | — |
| 4 | 4 | 0000950170-25-076408 | May 22, 2025 | — |
| 8-K | 8-K | 0000950170-25-076304 | May 22, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-013195 | May 15, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-002397 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-072765 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-001457 | May 12, 2025 | — |
| 8-K | 8-K | 0000950170-25-069195 | May 12, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-069226 | May 12, 2025 | Mar 31, 2025 |
| SCHEDULE 13G/A | — | 0002052113-25-001684 | Apr 24, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-001848 | Apr 17, 2025 | — |
| DEF 14A | DEF 14A | 0000950170-25-052874 | Apr 10, 2025 | May 22, 2025 |
| ARS | ARS | 0000950170-25-052878 | Apr 10, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0000950170-25-052876 | Apr 10, 2025 | — |
| SCHEDULE 13G | — | 0001172661-25-001361 | Mar 24, 2025 | — |
| SCHEDULE 13D/A | — | 0000919574-25-002011 | Mar 19, 2025 | — |
| 8-K | 8-K | 0000950170-25-037125 | Mar 11, 2025 | — |
| 10-K | 10-K | 0000950170-25-037131 | Mar 11, 2025 | Dec 31, 2024 |
| S-8 | S-8 | 0000950170-25-037136 | Mar 11, 2025 | — |
| 8-K | 8-K | 0000950170-25-033075 | Mar 5, 2025 | Mar 4, 2025 |
| 3 | 3 | 0000950170-25-033803 | Mar 5, 2025 | Mar 4, 2025 |
| 4 | 4 | 0000950170-25-033808 | Mar 5, 2025 | Mar 4, 2025 |
| SCHEDULE 13G/A | — | 0001415889-25-004279 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-020416 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001214659-25-002026 | Feb 5, 2025 | — |
| 4 | 4 | 0000950170-25-013443 | Feb 4, 2025 | Feb 3, 2025 |
| 4 | 4 | 0000950170-25-013471 | Feb 4, 2025 | Feb 3, 2025 |
| 4 | 4 | 0000950170-25-013485 | Feb 4, 2025 | Feb 3, 2025 |
| 4 | 4 | 0000950170-25-013488 | Feb 4, 2025 | Feb 3, 2025 |
| 4 | 4 | 0000950170-25-013516 | Feb 4, 2025 | Feb 3, 2025 |
| 8-K | 8-K | 0000950170-24-135775 | Dec 12, 2024 | — |
| SC 13D/A | — | 0000919574-24-006998 | Dec 3, 2024 | — |
| SC 13G | SC 13G | 0001193125-24-264379 | Nov 22, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-119322 | Nov 14, 2024 | — |